You can use a dermaroller after a hair transplant, provided the scalp has fully healed and the team looking after your follow-up has given you the go-ahead. No study has set a precise waiting period. Grafts are anchored after about ten days, yet the skin still has to finish healing, and microneedling is generally avoided straight after surgery and only brought in later (Balwi & Koldas, 2026).
Once you have that green light, it is best to start with a roller fitted with short needles of 0.25 to 0.5 mm, used without pressing down, once a week. The expected benefit mostly concerns your original hair: in people with androgenetic alopecia, adding microneedling to minoxidil increases hair count compared with minoxidil alone (Ahmed et al., 2025). Data specific to transplanted hair, on the other hand, remain scarce.
This guidance applies just as much after surgery in the UK as after a hair transplant in Turkey. A dermaroller is an optional extra: graft growth does not depend on it, and it replaces neither your post-operative instructions nor any treatment prescribed by a doctor.
A dermaroller is a small handheld roller fitted with fine needles that puncture the outer layer of the skin as it moves. These tiny punctures switch on the scalp’s wound-healing pathways and can make it easier for products applied afterwards to get through the skin (Balwi & Koldas, 2026). How the device works and how it is used against hair loss without surgery are covered in our article on the dermaroller for hair. After a transplant, three further questions come into play: when recently operated skin can safely be punctured again, how deep the needles should go and which areas to treat first.
The randomised trial by Dhurat et al. (2013) followed 100 men aged 20 to 35 with mild to moderate androgenetic alopecia. All of them applied 5% minoxidil twice a day for 12 weeks, and half also had a weekly session with a 1.5 mm roller. Within a fixed 1 cm² area, hair count rose by an average of 91.4 in the microneedling group, against 22.2 in the minoxidil-only group.
The meta-analysis by Ahmed et al. (2025) pools 12 randomised trials and 631 patients. It confirms a gain in both hair count and hair diameter when microneedling is added to minoxidil, with results that vary widely from one trial to the next. Side effects were somewhat more frequent (74 events against 59), but they were generally mild or settled on their own.
These trials assessed microneedling as a treatment for androgenetic alopecia, with no transplant involved. In their review of treatments used alongside hair transplantation, Balwi and Koldas (2026) note that transplant-specific data are limited: microneedling is usually avoided straight after surgery, then brought in later, mainly on non-transplanted or thinning areas. To date, no effect of a dermaroller on the survival or growth of the grafts themselves has been demonstrated.
The main benefit therefore lies around the grafts. Transplanted hair comes from the donor area at the back and sides of the head, and our complete guide to hair transplants explains why those follicles hold up against hair loss. Your native hair on top of the head, by contrast, remains exposed to androgenetic alopecia, and the NHS lists continued thinning around the transplanted area among the things that can go wrong after surgery (NHS, 2023). Slowing that thinning is what a maintenance treatment, possibly combined with microneedling, sets out to do.
During this period, the recipient area must be kept free of friction and pressure. Bernstein and Rassman (2006) tested, in 42 patients, the point at which a graft can no longer be pulled out. Tugging on a hair dislodged the graft every time during the first two days and never from the sixth day onwards, but pulling off an adherent scab still took the graft with it up to day five. By day nine, the grafts were no longer at risk.
Running a dermaroller over scabs would repeat exactly that risky movement. The washing and protection routine for these early days is set out in our article on hair transplant aftercare.
A well-anchored graft does not mean the skin is ready to be punctured. The recipient area can stay pink for a while, small spots sometimes appear as the new hair pushes through, and the donor area also needs its extraction points to close. The NHS advises taking great care of transplanted hair for the first two weeks, and notes that transplanted hairs commonly shed within a few weeks and grow back later (NHS, 2023).
This shedding is a normal stage of the transplant cycle. If it happens to coincide with your first sessions, you may wrongly blame the roller. Our page on the hair transplant timeline maps these stages month by month, up to the point when new hair appears, which the NHS places at around four months.
The right moment depends on the state of your scalp rather than on a date. Before a first session, there should be no scabs left after the transplant, on either the recipient or the donor area. The skin should neither weep nor bleed when washed, there should be no spots, and any redness should have clearly faded.
| State of the scalp | What to do |
|---|---|
| Scabs still present | No dermaroller yet |
| Spots, pus or a warm area | Ask the team first |
| Marked redness or pain | Wait and report it |
| Healed skin, no lesions | Possible once approved |
At Body Expert, this check is part of your 12 months of post-operative follow-up. When your scalp seems ready, you send photos of the recipient and donor areas, and the team will tell you whether a dermaroller is appropriate, on which area and how often.
The FDA, the US health regulator, separates these devices into two groups. Products with longer or sharp needles that genuinely penetrate the skin are medical devices, and the FDA recommends having them used by a healthcare professional with specific training. Rollers with short or blunt needles that claim only to exfoliate or improve the look of the skin fall outside that framework (FDA, 2025).
After a transplant, caution means sticking to needles of 0.25 to 0.5 mm. The 1.5 mm roller used in the trial by Dhurat et al. (2013) reaches much deeper and belongs in a supervised session. The meta-analysis by Ahmed et al. (2025) found no significant difference in hair count between needles of 1 mm or less and longer ones, nor between rollers and electric pens. A longer needle therefore has no proven advantage, while it punctures newly healed skin more deeply.
| Needle length | Use after a transplant |
|---|---|
| 0.25 mm | At home, sensitive skin |
| 0.5 mm | At home, once approved |
| 1 mm and above | Supervised sessions only |
As for frequency, participants in the Dhurat trial had one session a week. With a short roller, one session a week is a cautious starting point, which the team can then adjust according to how your scalp tolerates it. If redness from one session is still visible on the day planned for the next, put that next session back by a few days.
The roller should be yours alone and cleaned between uses, as directed by the manufacturer. The FDA advises against sharing these products with anyone, to avoid infection or passing on disease (FDA, 2025). A roller whose needles snag, bend or go blunt needs replacing, because it damages the skin instead of puncturing it cleanly. Each session then takes place on freshly washed and thoroughly dried hair, free of oils and styling products, with clean hands.
Roll the device in a few vertical, horizontal and then diagonal passes, lifting it to change direction rather than dragging it across the skin. In the trial by Dhurat et al. (2013), the session stopped as soon as mild redness appeared, even though the roller used was three times longer than a 0.5 mm model. Bleeding, sharp pain or intense redness mean you are pressing too hard.
Keep each session to the area agreed with the team. The donor area follows the same rule and is only treated once the extraction points have closed and are no longer tender. A dermaroller will not regrow the follicles taken from it, as they have left that area for good.
In the trial by Dhurat et al. (2013), minoxidil was paused on the day of the session and only resumed 24 hours later. Because punctured skin lets products through more easily, ask your pharmacist or prescriber how this timing applies to your own product and what its leaflet says about irritated or broken skin.
Keep serums, oils and over-the-counter lotions for the following day as well: the FDA mentions stinging or itching when skincare products are applied to freshly treated skin (FDA, 2025). Our separate guide to minoxidil and finasteride after a hair transplant explains when to restart those treatments after surgery.
Because microneedling can cause bleeding, the FDA says it may not be suitable if you have a clotting or bleeding disorder or take blood thinners, and suggests you may want to avoid it if you have eczema, diabetes or a weakened immune system (FDA, 2025). After a transplant, these situations call for medical advice before the first session, even with a short roller.
On the scalp itself, several situations mean waiting: a spot or pustule on the transplanted area, a flare of seborrhoeic dermatitis or psoriasis, a wound or sunburn. Rolling needles over a lesion that contains pus risks spreading germs into the neighbouring punctures. The signs that separate mild folliculitis from an infection after a hair transplant are explained in a dedicated article.
If you have ever developed thick or keloid scars, mention it before you start. Microneedling creates many small wounds, and the team will want to examine your skin before giving an opinion.
After a session, redness, a feeling of tightness, itching or light peeling are common. According to the FDA, these reactions usually clear up without treatment within a few days, sometimes a few weeks (FDA, 2025).
Other signs mean stopping the sessions and contacting the team: redness that spreads or deepens instead of fading, pain that gets worse, a warm area, discharge or pus, new scabs, or patches that look darker or lighter than the surrounding skin. The FDA also lists swollen lymph nodes and infection among the less common risks. A fever, or redness that is spreading quickly, needs medical attention without delay; for severe pain or any unexpected symptom after a transplant, the NHS advises contacting the clinic that carried it out as soon as possible (NHS, 2023).
To help the team respond, photograph the area in daylight, close up and from further away, and note the date of your last session and the needle length you used. These details help tell a passing irritation apart from a complication that needs an examination.
After surgery, the choice of a maintenance treatment depends on the stage of your hair loss, your age, your medical history and how well you tolerate each option, and it is that medical assessment which sets the order. Minoxidil and finasteride act on the hair loss itself and should be used on medical advice. In the trials described above, microneedling was always assessed alongside minoxidil, so its proven value is that of an add-on to that treatment.
PRP can also complement a transplant, on your surgeon’s recommendation, depending on the state of your native hair. None of these options is essential for the grafts to grow. On an area that has become smooth, where the follicles have gone, only a transplant brings new hair, because microneedling works on follicles that are still there.
Once your transplant has been carried out at our partner clinic in Istanbul, your 12-month post-operative follow-up continues remotely after you fly home. Redness that lingers after a session, a spot or a doubt about needle length can all be raised with your English-speaking patient coordinator, and the medical team then reviews them.
If your plans are still taking shape, our page on hair transplants in Istanbul describes the stay from arrival to the first wash at the clinic. Your quote is free, comes with no obligation and reaches you within 24 hours.
Ahmed, K. M. A., Kozaa, Y. A., Abuawwad, M. T., Al-Najdawi, A. I., Mahmoud, Y. W., Ahmed, A. M., Taha, M. J. J., Fadhli, T., & Giannopoulou, A. (2025). Evaluating the efficacy and safety of combined microneedling therapy versus topical minoxidil in androgenetic alopecia: A systematic review and meta-analysis. Archives of Dermatological Research, 317(1), 528. https://doi.org/10.1007/s00403-025-04032-1
Balwi, A., & Koldas, T. (2026). Adjunctive regenerative therapies in hair transplantation: A comprehensive review of platelet-rich plasma, exosomes, and emerging methods. Frontiers in Medicine, 13, 1820122. https://doi.org/10.3389/fmed.2026.1820122
Bernstein, R. M., & Rassman, W. R. (2006). Graft anchoring in hair transplantation. Dermatologic Surgery, 32(2), 198-204. https://doi.org/10.1111/j.1524-4725.2006.32033.x
Dhurat, R., Sukesh, M. S., Avhad, G., Dandale, A., Pal, A., & Pund, P. (2013). A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: A pilot study. International Journal of Trichology, 5(1), 6-11. https://doi.org/10.4103/0974-7753.114700
National Health Service. (2023, September 29). Hair transplant. NHS. https://www.nhs.uk/tests-and-treatments/cosmetic-procedures/cosmetic-surgery/hair-transplant/
U.S. Food and Drug Administration. (2025, October 15). Microneedling devices: Getting to the point on benefits, risks and safety. FDA. https://www.fda.gov/consumers/consumer-updates/microneedling-devices-getting-point-benefits-risks-and-safety